CN104644522A - 透皮美容的组合制剂和试剂盒及其制备方法 - Google Patents
透皮美容的组合制剂和试剂盒及其制备方法 Download PDFInfo
- Publication number
- CN104644522A CN104644522A CN201510028407.XA CN201510028407A CN104644522A CN 104644522 A CN104644522 A CN 104644522A CN 201510028407 A CN201510028407 A CN 201510028407A CN 104644522 A CN104644522 A CN 104644522A
- Authority
- CN
- China
- Prior art keywords
- transdermal
- preparation
- semigel
- cell suspension
- beauty treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 47
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims abstract description 30
- 102000008186 Collagen Human genes 0.000 claims abstract description 19
- 108010035532 Collagen Proteins 0.000 claims abstract description 19
- 239000006285 cell suspension Substances 0.000 claims abstract description 19
- 229920001436 collagen Polymers 0.000 claims abstract description 15
- 210000005259 peripheral blood Anatomy 0.000 claims abstract description 15
- 239000011886 peripheral blood Substances 0.000 claims abstract description 15
- 238000000338 in vitro Methods 0.000 claims abstract description 8
- 239000011159 matrix material Substances 0.000 claims abstract description 8
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims abstract description 4
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims abstract description 4
- 230000001815 facial effect Effects 0.000 claims description 49
- 238000011282 treatment Methods 0.000 claims description 45
- 239000010408 film Substances 0.000 claims description 37
- 210000004027 cell Anatomy 0.000 claims description 35
- 230000003796 beauty Effects 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 23
- 239000003814 drug Substances 0.000 claims description 17
- 230000008569 process Effects 0.000 claims description 14
- 210000002536 stromal cell Anatomy 0.000 claims description 13
- 238000012360 testing method Methods 0.000 claims description 12
- 239000012531 culture fluid Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 102000004127 Cytokines Human genes 0.000 claims description 9
- 108090000695 Cytokines Proteins 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 6
- 229920001503 Glucan Polymers 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 210000000744 eyelid Anatomy 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000010409 thin film Substances 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- 239000004925 Acrylic resin Substances 0.000 claims description 2
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims description 2
- 102100020880 Kit ligand Human genes 0.000 claims description 2
- 101710177504 Kit ligand Proteins 0.000 claims description 2
- 102000015336 Nerve Growth Factor Human genes 0.000 claims description 2
- 108010025020 Nerve Growth Factor Proteins 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 101710098940 Pro-epidermal growth factor Proteins 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 19
- 230000037303 wrinkles Effects 0.000 abstract description 11
- 210000004623 platelet-rich plasma Anatomy 0.000 abstract description 5
- 230000035755 proliferation Effects 0.000 abstract description 4
- 101800003838 Epidermal growth factor Proteins 0.000 abstract 2
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 abstract 2
- 229940116977 epidermal growth factor Drugs 0.000 abstract 2
- 239000002994 raw material Substances 0.000 abstract 2
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 abstract 2
- 230000009758 senescence Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 44
- 206010040954 Skin wrinkling Diseases 0.000 description 11
- 210000004748 cultured cell Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 230000010261 cell growth Effects 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 210000005087 mononuclear cell Anatomy 0.000 description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
- 208000031481 Pathologic Constriction Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000000589 cicatrix Anatomy 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000003102 growth factor Substances 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- 210000001215 vagina Anatomy 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 4
- 206010008570 Chloasma Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 208000003351 Melanosis Diseases 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 238000010612 desalination reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000002673 Dioscorea communis Nutrition 0.000 description 2
- 241000544230 Dioscorea communis Species 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 208000035753 Periorbital contusion Diseases 0.000 description 2
- 240000003864 Ulex europaeus Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000890 drug combination Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003677 hemocyte Anatomy 0.000 description 2
- 229940000351 hemocyte Drugs 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000008470 skin growth Effects 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000015294 blood coagulation disease Diseases 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510028407.XA CN104644522A (zh) | 2015-01-21 | 2015-01-21 | 透皮美容的组合制剂和试剂盒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510028407.XA CN104644522A (zh) | 2015-01-21 | 2015-01-21 | 透皮美容的组合制剂和试剂盒及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104644522A true CN104644522A (zh) | 2015-05-27 |
Family
ID=53236500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510028407.XA Pending CN104644522A (zh) | 2015-01-21 | 2015-01-21 | 透皮美容的组合制剂和试剂盒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104644522A (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106943336A (zh) * | 2017-05-25 | 2017-07-14 | 西南医科大学 | 一种prp/磷脂脂质体透皮制剂及其制备方法 |
CN108498941A (zh) * | 2018-04-25 | 2018-09-07 | 武汉德丽福生物科技有限公司 | 微针美容贴片以及其制备方法 |
WO2018196109A1 (zh) * | 2017-04-27 | 2018-11-01 | 苏州纳通生物纳米技术有限公司 | 微型针在皮肤清洁中的应用 |
CN108815114A (zh) * | 2018-07-13 | 2018-11-16 | 深圳市润科生物科技有限公司 | 一种美容针剂及其制备方法 |
CN109125106A (zh) * | 2018-08-06 | 2019-01-04 | 上海优萃生物科技有限公司 | 一种祛皱原液及其在皮肤促渗技术上的应用 |
PL422533A1 (pl) * | 2017-08-11 | 2019-02-25 | Urszula Halina Brumer | Sposób otrzymywania preparatu z krwi obwodowej zawierającego komórki jednojądrzaste |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009235004A (ja) * | 2008-03-27 | 2009-10-15 | J Hewitt Kk | 細胞組織増加促進方法及び肌問題改善方法並びにこれらに用いるキット |
CN101785852A (zh) * | 2010-01-21 | 2010-07-28 | 孙杰 | 一种真皮层微量介入美容抗衰除皱制剂与方法 |
CN104173252A (zh) * | 2014-07-29 | 2014-12-03 | 蔡贤芬 | 一种含自体基质细胞的生物美容制剂 |
-
2015
- 2015-01-21 CN CN201510028407.XA patent/CN104644522A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009235004A (ja) * | 2008-03-27 | 2009-10-15 | J Hewitt Kk | 細胞組織増加促進方法及び肌問題改善方法並びにこれらに用いるキット |
CN101785852A (zh) * | 2010-01-21 | 2010-07-28 | 孙杰 | 一种真皮层微量介入美容抗衰除皱制剂与方法 |
CN104173252A (zh) * | 2014-07-29 | 2014-12-03 | 蔡贤芬 | 一种含自体基质细胞的生物美容制剂 |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018196109A1 (zh) * | 2017-04-27 | 2018-11-01 | 苏州纳通生物纳米技术有限公司 | 微型针在皮肤清洁中的应用 |
CN106943336A (zh) * | 2017-05-25 | 2017-07-14 | 西南医科大学 | 一种prp/磷脂脂质体透皮制剂及其制备方法 |
CN106943336B (zh) * | 2017-05-25 | 2020-04-03 | 西南医科大学 | 一种prp/磷脂脂质体透皮制剂及其制备方法 |
PL422533A1 (pl) * | 2017-08-11 | 2019-02-25 | Urszula Halina Brumer | Sposób otrzymywania preparatu z krwi obwodowej zawierającego komórki jednojądrzaste |
CN108498941A (zh) * | 2018-04-25 | 2018-09-07 | 武汉德丽福生物科技有限公司 | 微针美容贴片以及其制备方法 |
CN108815114A (zh) * | 2018-07-13 | 2018-11-16 | 深圳市润科生物科技有限公司 | 一种美容针剂及其制备方法 |
CN108815114B (zh) * | 2018-07-13 | 2021-06-15 | 深圳市润科生物科技有限公司 | 一种美容针剂及其制备方法 |
CN109125106A (zh) * | 2018-08-06 | 2019-01-04 | 上海优萃生物科技有限公司 | 一种祛皱原液及其在皮肤促渗技术上的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104644522A (zh) | 透皮美容的组合制剂和试剂盒及其制备方法 | |
CN102552099B (zh) | 一种用于皮肤美容修复的复合生物制剂及制备方法 | |
CN107854418A (zh) | 一种人脐带间充质干细胞外泌体外用乳霜及其制备方法 | |
CN104203211A (zh) | 以非人类干细胞的培养上清为原材料的化妆品或皮肤再生促进剂以及蛋白质的离子导入方法 | |
CN106190967A (zh) | 一种自体脂肪源干细胞用于美容抗衰的制备方法 | |
CN103908424A (zh) | 一种用于美容保养的精华液及其制备方法 | |
CN102586182A (zh) | 人源干细胞分泌生物活性因子与裂解液的制备与应用 | |
CN105056303A (zh) | 一种组合物、制剂及其用途 | |
CN111110623A (zh) | 自体修复小小针营养液配方 | |
CN104288129A (zh) | 一种用于抗皱祛斑的干细胞微针贴片及其制备方法 | |
CN105055265A (zh) | 一种美容养颜产品及其制备方法 | |
CN104546639B (zh) | 一种干细胞精华素及其制备方法 | |
CN111544371B (zh) | 含有益生菌活性提取液和烟酰胺的美白修复面膜 | |
CN110396497A (zh) | 基于自体脂肪干细胞外泌体的制备及美容方法 | |
CN109908180A (zh) | 用于治疗子宫内膜损伤的子宫内膜干细胞外泌体浓缩液凝胶制剂及其制备方法与给药方法 | |
CN109893542A (zh) | 用于治疗勃起功能障碍的干细胞外泌体浓缩液凝胶制剂及其制备方法与给药方法 | |
CN107550846A (zh) | 一种用于美容护肤的干细胞活性复合制剂及其制备方法 | |
CN102233144A (zh) | 一种利用组织工程技术进行皮下组织再生的方法 | |
CN107779430A (zh) | 脐带间充质干细胞上清液的收集方法 | |
CN105597088A (zh) | 一种制剂、其制备方法及其应用 | |
CN115651901A (zh) | 一种脐带来源间充质干细胞外泌体的制备方法、制备的外泌体及应用 | |
CN109646459A (zh) | 一种水光注射仪注射脐带间充质干细胞制剂及其应用 | |
RU2308957C1 (ru) | Способ получения препарата для мезотерапии и препарат, полученный этим способом (варианты) | |
CN114832015A (zh) | 一种基于prp与干细胞外泌体的面部修复注射剂及其制备方法 | |
CN101804071A (zh) | 一种治疗皮肤缺损的注射剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: 100085, B222, 5 Street, seven street, Beijing, Haidian District Applicant after: BEIJING HONGRUN TIANYUAN BIOTECHNOLOGY CO.,LTD. Address before: 100085 Zhongguancun biological medicine Park, No. 5, Pioneer Road, Beijing, Haidian District, B110 Applicant before: CELLONIS BIOTECHNOLOGIES Co.,Ltd. |
|
COR | Change of bibliographic data | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 100085 B222, No. 5, Pioneer Road, Shangdi Seventh Street, Haidian District, Beijing Applicant after: BEIJING CELLONIS GENE BIOTECHNOLOGY Co.,Ltd. Address before: 100085 B222, No. 5, Pioneer Road, Shangdi Seventh Street, Haidian District, Beijing Applicant before: BEIJING HONGRUN TIANYUAN BIOTECHNOLOGY CO.,LTD. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: BEIJING CELLONIS GENE BIOTECHNOLOGY Co.,Ltd. Person in charge of patents Document name: Deemed withdrawal notice |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150527 |